CD151 and ovarian carcinoma: Meanwhile, expression of α3 integrin in luminal cells appear unaffected, implicating that the tumor-suppressive role of CD151 in breast, prostate and ovarian cancers are attributed to the combined action of integrin- and self-associated CD151 molecules.